May 2019 |
|
Wyden, Grassley Demand Answers on Misconduct and Abuse at Federally-Funded Facilities Caring for Unaccompanied Migrant Children
|
|
Grassley Statement on Direct-to-Consumer Prescription Advertising
|
|
Grassley, Durbin Statement on HHS Rule to Require Disclosure of Prescription Drug Prices in TV Ads
|
|
Grassley, Wyden Press IRS for Accountability Regarding the Free File Program
|
|
Grassley Op-ed: Democrats are dishonest on taxes, trying to distract from economy on the move
|
|
Grassley to NIH: Take Red Flags in Clinical Trials Seriously
|
|
Grassley Statement on White House Meeting on Trade
|
|
Grassley Presses IRS for Answers on Potential Lawbreaking by Agency Employees
|
|
Grassley Announces Medicare Physician Payments Hearing
|
|
Grassley Statement on CBO “Medicare for All” Report
|
|
Grassley on Opportunity Zones
|
|
Grassley on the Conclusion of Tax Filing Season
|
April 2019 |
|
Data Shows Private Debt Collection Program is Working
|
|
Finance Committee Releases Report on Medicaid Supplemental Payments
|
|
Grassley Discusses Trump’s Trade Agenda on “Fox and Friends”
|
|
Grassley on the EpiPen: A Case Study in the Value of Oversight to Find Legislative Solutions
|
|
Grassley WSJ Op-ed: Trump's Tariffs End or His Trade Deal Dies
|
|
Grassley Op-ed: A Bipartisan Effort to End Robocalls
|
|
Grassley Statement on Social Security and Medicare Annual Report
|
|
Chairman Grassley Op-ed: Protecting Vulnerable Seniors Through Congressional Oversight
|